Syntis Bio Closes $38M Series A Financing

| Posted on |

Here’s the summarized information regarding Syntis Bio:

Company Overview

  • Startup: Syntis Bio
  • Founders: Rahul Dhanda (CEO)
  • Location: Boston, MA
  • Website: syntis.bio

Fundraising Details

  • Series: Series A
  • Amount Raised: $38 million
  • Date: January 7, 2025

Investors Involved

  • Lead Investor: Cerberus Ventures
  • Participating Investors:
    • Mansueto Investments
    • Woori Venture Partners
    • Apollo Labs
    • BOLD Capital Partners
    • W. R. Berkley Corporation
    • Safar Partners
    • Portal Innovations
    • Colorcon Ventures
    • Cerity Partners Ventures

Additional Funding

  • Non-Dilutive Funding: Up to $5 million from NIH through two SBIR awards.

Focus

  • Industry: Biopharmaceuticals
  • Therapeutic Areas: Obesity, diabetes, rare diseases

This concise overview provides a quick reference to the key aspects of Syntis Bio’s funding and operations.

Source link

2025-07-01 15:21:12